RTHM connects you with a digital care team specializing in Long COVID and ME/CFS that provides access to a range of therapies based on the latest research.
Jun 30 • 9 tweets • 3 min read
A new study suggests that exercise doesn’t clear microclots in people with Long COVID—it just fragments them into smaller ones. These smaller clots are linked to increased inflammation and impaired oxygen transport, which may help explain post-exertional malaise (PEM) and post-exertional symptom exacerbation (PESE)—a worsening of symptoms after even mild physical or mental effort.
Researchers observed these microclot and inflammatory changes even after submaximal exertion, highlighting the need for caution when recommending exercise-based therapies.
Want more research breakdowns like this? Sign up for our email list at linktr.ee/rthm_health
A new study from New Zealand found that over one-third of university students experienced measurable cognitive deficits—especially in executive function—up to 17 months after COVID-19 infection.
Even in a young, healthy population, the impacts on brain function were objectively detectable using neuropsych testing and brain oxygenation data.
Want insights like this sent straight to your inbox? Click on our linktree to join our email list for research breakdowns, treatment updates, and tools for navigating Long COVID and ME/CFS.
New research shows SARS-CoV-2 infection particles can persist in semen for up to 8 months after infection, raising critical questions about viral reservoirs and potential sexual transmission. The virus remained detectable in over half the study participants and was confirmed as infectious through cell culture. While decreased sperm quality showed signs of recovery by 6 months, the implications of viral persistence in the male genital tract remain under investigation.
This study adds to growing evidence that the male reproductive system may serve as an immune privileged site for virus reservoirs, similar to findings in Post-Ebola Syndrome.
Click below to sign up for our email list to receive updates about the latest research.
Even Olympic athletes aren’t bouncing back from COVID.
A new study out of Germany found that nearly 40% of elite athletes across several sports had reduced performance lasting >4 months after acute COVID-19. This was despite the majority having mild acute infections and none of the athletes having pre-existing health conditions.
Fatigue, shortness of breath, and pain were common, persisting symptoms, indicating a need to change current return-to-play protocols for athletes.
Want updates on the latest research and treatment options? Join our email list.
We’re excited to announce RTHM Direct is now offering Ivabradine. We’ve seen this medication make a significant difference for patients with #LongCovid, #POTS, & #MECFS — and are excited to expand its access. Here’s everything you need to know 👇🧵
What Is Ivabradine?
It is an FDA-approved medication designed to reduce heart rate without affecting blood pressure that works by slowing the activity of the “pacemaker cells” in the heart. It specifically reduces heart rate without lowering blood pressure.
Dec 13, 2024 • 6 tweets • 2 min read
Is #LongCovid a national security issue?
The CHARM 2.0 study conducted reveals striking findings about Long COVID’s impact on even the fittest among us. Among 899 young, healthy Marines, nearly 25% developed Long COVID, with lasting effects on productivity, physical fitness, and overall performance—despite most having mild initial infections.
Swipe to learn more about this pivotal study and why Long COVID must remain a public health priority.
